EVANGELIA NEZIS: Open Payments
NPI 1083224968 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,588 in 210 payments from 21 companies in 2025. Trend: 2023 $3,094 · 2024 $6,496 · 2025 $8,588
Food & beverage: $8,472Education: $116
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 31 | $1,294 |
| GENZYME CORPORATION | 19 | $1,037 |
| ABBVIE INC. | 35 | $986 |
| Amgen Inc. | 15 | $842 |
| Regeneron Healthcare Solutions, Inc. | 12 | $785 |
| Organon LLC | 13 | $639 |
| Incyte Corporation | 9 | $560 |
| LEO Pharma Inc. | 13 | $450 |
| UCB, Inc. | 12 | $389 |
| Arcutis Biotherapeutics, Inc. | 10 | $383 |
Products named: DUPIXENT, NEMLUVIO, Otezla, RINVOQ, VTAMA, Opzelura, Bimzelx, Zoryve.
Industry payments across NY — which companies pay providers there.
